ARTICLE | Company News
Marina Biotech cancer news
February 20, 2012 8:00 AM UTC
Marina said it will close its Cambridge, Mass., R&D site and moved all R&D efforts to its headquarters in Bothell in order to save cash. Marina's CEQ508, an oral RNAi targeting beta-catenin (CTNNB1)...